Core Laboratories N.V.
CLB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $581,884 | $547,304 | $701,127 | $810,572 |
| - Cash | $25,629 | $31,188 | $22,107 | $19,157 |
| + Debt | $41,525 | $42,420 | $180,002 | $180,144 |
| Enterprise Value | $597,780 | $558,536 | $859,022 | $971,559 |
| Revenue | $134,521 | $130,159 | $123,585 | $129,237 |
| % Growth | 3.4% | 5.3% | -4.4% | – |
| Gross Profit | $26,026 | $22,788 | $20,399 | $19,374 |
| % Margin | 19.3% | 17.5% | 16.5% | 15% |
| EBITDA | $24,522 | $22,645 | $8,097 | $17,838 |
| % Margin | 18.2% | 17.4% | 6.6% | 13.8% |
| Net Income | $14,239 | $10,636 | -$154 | $7,403 |
| % Margin | 10.6% | 8.2% | -0.1% | 5.7% |
| EPS Diluted | 0.3 | 0.22 | -0.003 | 0.16 |
| % Growth | 36.4% | 6,766.7% | -102.1% | – |
| Operating Cash Flow | $8,502 | $14,717 | $6,660 | $20,615 |
| Capital Expenditures | -$3,032 | -$4,633 | -$3,579 | -$4,381 |
| Free Cash Flow | $5,470 | $10,084 | $3,081 | $16,234 |